Puzyński S, Hauptmann M, Rode A, Kalinowski A, Bidzińska E, Beresewicz M, Bidziński A
II Kliniki Psychiatrycznej Instytutu Psychiatrii i Neurologii w Warszawie.
Psychiatr Pol. 1990 May-Jun;24(3):202-8.
In the group of 115 endogenous depression patients 84 responded to tricyclic antidepressant medication and 31 remained drug-resistance. The changes of platelet MAO activity and serum DBH activity in the latter group were found. Among drug-resistant patients, 40% showed low MAO/DBH index (.6) and in 36% the index was within the medium range (.6-1.9). The low value of the index is predominantly connected with the increase of DBH and decrease of MAO activity, and it may become the potential predictive factor for the pharmacotherapy in endogenous depression. The results show the influence of the disturbances of catecholamines synthesis and degradation on the phenomenon of drug-resistance to tricyclic antidepressants.
在115名内源性抑郁症患者组中,84人对三环类抗抑郁药有反应,31人仍耐药。研究发现了后一组患者血小板单胺氧化酶(MAO)活性和血清多巴胺β-羟化酶(DBH)活性的变化。在耐药患者中,40%的人MAO/DBH指数较低(<0.6),36%的人该指数处于中等范围(0.6 - 1.9)。该指数的低值主要与DBH增加和MAO活性降低有关,它可能成为内源性抑郁症药物治疗的潜在预测因素。结果表明儿茶酚胺合成和降解紊乱对三环类抗抑郁药耐药现象的影响。